サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：スマートインスリンペンの世界市場の評価：タイプ別、適応症別、使用性別、製品別、接続性別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）
市場調査レポート
商品コード
1422083

スマートインスリンペンの世界市場の評価：タイプ別、適応症別、使用性別、製品別、接続性別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）

Smart Insulin Pens Market Assessment, By Type, By Indication, By Usability, By Product, By Connectivity, By End-user, By Distribution Channel, By Region, By Opportunities and Forecast, 2017-2031F
出版日: | 発行: Market Xcel - Markets and Data | ページ情報: 英文 221 Pages | 納期: 3～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
スマートインスリンペンの世界市場の評価：タイプ別、適応症別、使用性別、製品別、接続性別、エンドユーザー別、流通チャネル別、地域別、機会、予測（2017年～2031年）
出版日: 2024年02月07日
発行: Market Xcel - Markets and Data
ページ情報: 英文 221 Pages
納期: 3～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のスマートインスリンペンの市場規模は、2023年に5,140万米ドル、2031年に1億2,909万米ドルに達し、2024年～2031年の予測期間にCAGRで12.2%の成長が見込まれています。糖尿病の有病率の増加、血糖値管理の向上、患者の利便性向上、継続的な技術の進歩、遠隔医療の重視、意識の高まり、投薬ミスリスクの最小化、潜在的な医療コスト削減などの多数の要因が世界のスマートインスリンペン市場を推進しています。

世界のスマートインスリンペン市場は、糖尿病管理における大きな飛躍を意味します。これらの画期的なデバイスは、糖尿病患者のインスリン投与プロセスに革命をもたらし、精度の向上、利便性の向上、データドリブンな知見を提供し、全体的なウェルビーイングと生活の質を向上させます。世界の糖尿病の流行と、効率的で使いやすい糖尿病管理ツールへのニーズの高まりが、世界のスマートインスリンペン市場の拡大を後押ししています。医療提供者も患者も、インスリン療法を改善し、より効果的な血糖コントロールと糖尿病に伴う長期合併症の減少につながるこれらのデバイスの可能性を認めるようになってきています。

メーカーによる技術の進化とますます精巧化した機能と接続性オプションの導入により、世界のスマートインスリンペン市場は継続的な成長に位置づけられています。スマートインスリンペンは、自動化された正確な用量計算を容易にする技術を備えており、インスリン投与中の人的ミスの可能性を減少させます。これらのデバイスは、頻繁にスマートフォンアプリと無線接続を確立し、ユーザーがインスリン投与履歴、血糖値、その他の重要なデータを追跡することを可能にします。このことは、糖尿病管理の改善と、この慢性疾患を持つ個人の自立性向上への有望な見通しを提示します。

高まる意識

糖尿病のモニタリングとコントロールにスマートな方法を用いることへの意識の高まりが、世界のスマートインスリンペン市場の大きな成長につながっています。糖尿病ケアは、従来の対面診察から、ビデオ診察のような同期型の遠隔医療の手法に移行しつつあり、主に市場の新興企業が提供する非同期型のデジタル医療サービスも増えています。米国ではインスリンペンの利用が過去数十年間で着実に増加しており、1型糖尿病（T1D）と2型糖尿病（T2D）の両方の患者に好まれるインスリン投与方法となっています。インスリンペンは現在、商業保険加入者の間で市場を独占しています。患者がインスリンペンを選ぶ理由は、インスリンバイアルやシリンジ方式に比べて満足度が高く、使いやすいからです。これらのペンは優れた投与精度を提供し、インスリンのアドヒアランス向上につながります。さらに、インスリンペンの使用はHbA1c値を低下させ、高血糖を最小限に抑え、よりよい血糖コントロールを実証しています。初期費用が高いとはいえ、インスリンペンは総医療費の削減につながり、その結果、入院、糖尿病関連の入院、高血糖に関連した医療利用が減少します。

技術の進歩が市場を前進させる

技術革新は、世界のスマートインスリンペン市場の領域を一変させました。これらの開発には、正確な用量計算、即時のスマートフォンデータ統合、ユーザーフレンドリーなインターフェースなどが含まれます。スマートインスリンペンの進化は、人々に健康管理の効率的な手段を提供し、最終的にウェルビーイングの向上と生活の質の改善をもたらします。例えば、2023年3月、自動インスリンデリバリーの先駆者であるDiabeloopは、著名なグローバル医療企業であるNovo Nordiskとの提携を明らかにしました。両社の取り組みは、コネクテッドインスリンペンを組み込んだ相互運用性戦略の推進に焦点を当てています。この契約は、Diabeloopの自己学習型MDI（Multiple Daily Injections）療法用アルゴリズムであるDBL-4pen（TM）と、Novo NordiskのNovoPen（R）6やNovoPen Echo（R）Plusなどの再使用可能なコネクテッドインスリンペンの統合を含みます。

当レポートでは、世界のスマートインスリンペン市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 世界のスマートインスリンペン市場に対するCOVID-19の影響

第4章 エグゼクティブサマリー

第5章 世界のスマートインスリンペン市場の見通し（2014年～2031年）

  • 市場規模と予測
    • 金額
    • 数量
  • タイプ別
    • 第1世代のペン
    • 第2世代のペン
  • 適応症別
    • 1型糖尿病
    • 2型糖尿病
  • 使用性別
    • 使い捨て
    • 再使用可能
  • 製品別
    • スマートインスリンペン
    • 従来型ペン用アダプター
  • エンドユーザー別
    • 病院、診療所
    • 外来手術センター
    • 在宅ケア環境
  • 流通チャネル別
    • 診療所、外来手術センター
    • eコマース
    • 小売薬局
  • 地域別
    • 北米
    • 南米
    • 欧州
    • アジア太平洋
    • 中東・アフリカ
  • 市場シェア：企業別（2023年）

第6章 世界のスマートインスリンペン市場の見通し：地域別（2014年～2031年）

  • 北米
    • 市場規模と予測
    • タイプ別
    • 適応症別
    • 使用性別
    • 製品別
    • エンドユーザー別
    • 流通チャネル別
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • イタリア
    • 英国
    • ロシア
    • オランダ
    • スペイン
    • トルコ
    • ポーランド
  • 南米
    • ブラジル
    • アルゼンチン
  • アジア太平洋
    • インド
    • 中国
    • 日本
    • オーストラリア
    • ベトナム
    • 韓国
    • インドネシア
    • フィリピン
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ

第7章 市場マッピング（2023年）

  • タイプ別
  • 適応症別
  • 使用性別
  • 製品別
  • エンドユーザー別
  • 流通チャネル別
  • 地域別

第8章 マクロ環境と産業構造

  • 需給分析
  • 輸出入の分析
  • バリューチェーン分析
  • PESTEL分析
  • ポーターのファイブフォース分析

第9章 市場力学

  • 成長促進要因
  • 成長抑制要因（課題、抑制要因）

第10章 規制枠組みとイノベーション

  • 臨床試験
  • 特許情勢
  • 規制当局の承認
  • イノベーション/新技術

第11章 主要企業情勢

  • マーケットリーダー上位5社の競合マトリクス
  • マーケットリーダー上位5社の市場収益分析（2023年）
  • 合併と買収/合弁事業（該当する場合）
  • SWOT分析（市場参入企業5社）
  • 特許分析（該当する場合）

第12章 価格分析

第13章 ケーススタディ

第14章 主要企業の見通し

  • Novo Nordisk A/S
  • Medtronic plc.
  • Sanofi S.A.
  • Eli Lilly International Corp.
  • Dexcom, Inc.
  • Emperra GmbH E-Health Technologies
  • Bigfoot Biomedical, INC.
  • Jiangsu Delfu medical device Co. Ltd.
  • Digital Medics Pty Ltd.
  • Glooko XT
  • Biocorp Production
  • Pendiq GmbH

第15章 戦略的推奨事項

第16章 当社について、免責事項

図表

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 2. Global Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 3. Global Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 4. Global Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 5. Global Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 6. Global Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 7. Global Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 8. Global Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 9. Global Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 10. Global Smart Insulin Pens Market Share (%), By Region, 2017-2031F
  • Figure 11. North America Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 12. North America Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 13. North America Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 14. North America Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 15. North America Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 16. North America Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 17. North America Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 18. North America Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 19. North America Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 20. North America Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 21. United States Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 22. United States Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 23. United States Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 24. United States Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 25. United States Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 26. United States Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 27. United States Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 28. United States Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 29. United States Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 30. Canada Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 31. Canada Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 32. Canada Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 33. Canada Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 34. Canada Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 35. Canada Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 36. Canada Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 37. Canada Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 38. Canada Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 39. Mexico Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 40. Mexico Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 41. Mexico Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 42. Mexico Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 43. Mexico Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 44. Mexico Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 45. Mexico Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 46. Mexico Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 47. Mexico Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 48. Europe Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 49. Europe Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 50. Europe Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 51. Europe Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 52. Europe Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 53. Europe Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 54. Europe Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 55. Europe Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 56. Europe Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 57. Europe Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 58. Germany Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 59. Germany Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 60. Germany Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 61. Germany Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 62. Germany Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 63. Germany Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 64. Germany Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 65. Germany Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 66. Germany Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 67. France Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 68. France Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 69. France Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 70. France Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 71. France Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 72. France Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 73. France Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 74. France Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 75. France Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 76. Italy Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 77. Italy Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 78. Italy Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 79. Italy Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 80. Italy Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 81. Italy Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 82. Italy Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 83. Italy Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 84. Italy Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 85. United Kingdom Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 86. United Kingdom Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 87. United Kingdom Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 88. United Kingdom Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 89. United Kingdom Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 90. United Kingdom Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 91. United Kingdom Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 92. United Kingdom Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 93. United Kingdom Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. Russia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 95. Russia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 96. Russia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 97. Russia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 98. Russia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 99. Russia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 100. Russia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 101. Russia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 102. Russia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 103. Netherlands Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 104. Netherlands Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 105. Netherlands Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 106. Netherlands Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 107. Netherlands Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 108. Netherlands Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 109. Netherlands Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 110. Netherlands Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 111. Netherlands Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 112. Spain Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 113. Spain Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 114. Spain Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 115. Spain Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 116. Spain Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 117. Spain Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 118. Spain Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 119. Spain Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 120. Spain Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 121. Turkey Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 122. Turkey Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 123. Turkey Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 124. Turkey Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 125. Turkey Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 126. Turkey Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 127. Turkey Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 128. Turkey Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 129. Turkey Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 130. Poland Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 131. Poland Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 132. Poland Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 133. Poland Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 134. Poland Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 135. Poland Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 136. Poland Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 137. Poland Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 138. Poland Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 139. South America Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 140. South America Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 141. South America Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 142. South America Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 143. South America Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 144. South America Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 145. South America Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 146. South America Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 147. South America Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 148. South America Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 149. Brazil Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 150. Brazil Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 151. Brazil Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 152. Brazil Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 153. Brazil Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 154. Brazil Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 155. Brazil Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 156. Brazil Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 157. Brazil Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 158. Argentina Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 159. Argentina Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 160. Argentina Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 161. Argentina Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 162. Argentina Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 163. Argentina Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 164. Argentina Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 165. Argentina Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 166. Argentina Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 167. Asia-Pacific Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 168. Asia-Pacific Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 169. Asia-Pacific Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 170. Asia-Pacific Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 171. Asia-Pacific Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 172. Asia-Pacific Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 173. Asia-Pacific Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 174. Asia-Pacific Smart Insulin Pens Market Share (%), By End-user, In USD Million, 2016-2030
  • Figure 175. Asia-Pacific Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 176. Asia-Pacific Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 177. India Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 178. India Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 179. India Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 180. India Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 181. India Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 182. India Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 183. India Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 184. India Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 185. India Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 186. China Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 187. China Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 188. China Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 189. China Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 190. China Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 191. China Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 192. China Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 193. China Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 194. China Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 195. Japan Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 196. Japan Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 197. Japan Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 198. Japan Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 199. Japan Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 200. Japan Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 201. Japan Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 202. Japan Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 203. Japan Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 204. Australia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 205. Australia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 206. Australia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 207. Australia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 208. Australia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 209. Australia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 210. Australia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 211. Australia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 212. Australia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 213. Vietnam Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 214. Vietnam Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 215. Vietnam Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 216. Vietnam Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 217. Vietnam Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 218. Vietnam Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 219. Vietnam Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 220. Vietnam Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 221. Vietnam Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 222. South Korea Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 223. South Korea Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 224. South Korea Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 225. South Korea Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 226. South Korea Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 227. South Korea Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 228. South Korea Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 229. South Korea Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 230. South Korea Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 231. Indonesia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 232. Indonesia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 233. Indonesia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 234. Indonesia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 235. Indonesia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 236. Indonesia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 237. Indonesia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 238. Indonesia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 239. Indonesia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 240. Philippines Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 241. Philippines Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 242. Philippines Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 243. Philippines Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 244. Philippines Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 245. Philippines Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 246. Philippines Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 247. Philippines Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 248. Philippines Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 249. Middle East & Africa Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 250. Middle East & Africa Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 251. Middle East & Africa Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 252. Middle East & Africa Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 253. Middle East & Africa Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 254. Middle East & Africa Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 255. Middle East & Africa Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 256. Middle East & Africa Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 257. Middle East & Africa Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 258. Middle East & Africa Smart Insulin Pens Market Share (%), By Country, 2017-2031F
  • Figure 259. Saudi Arabia Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 260. Saudi Arabia Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 261. Saudi Arabia Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 262. Saudi Arabia Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 263. Saudi Arabia Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 264. Saudi Arabia Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 265. Saudi Arabia Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 266. Saudi Arabia Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 267. Saudi Arabia Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 268. UAE Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 269. UAE Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 270. UAE Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 271. UAE Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 272. UAE Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 273. UAE Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 274. UAE Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 275. UAE Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 276. UAE Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 277. South Africa Smart Insulin Pens Market, By Value, In USD Million, 2017-2031F
  • Figure 278. South Africa Smart Insulin Pens Market, By Volume, In Thousand, 2017-2031F
  • Figure 279. South Africa Smart Insulin Pens Market Share (%), By Type, 2017-2031F
  • Figure 280. South Africa Smart Insulin Pens Market Share (%), By Indication, 2017-2031F
  • Figure 281. South Africa Smart Insulin Pens Market Share (%), By Usability, 2017-2031F
  • Figure 282. South Africa Smart Insulin Pens Market Share (%), By Product, 2017-2031F
  • Figure 283. South Africa Smart Insulin Pens Market Share (%), By Connectivity, 2017-2031F
  • Figure 284. South Africa Smart Insulin Pens Market Share (%), By End-user, 2017-2031F
  • Figure 285. South Africa Smart Insulin Pens Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 286. By Type Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 287. By Indication Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 288. By Usability Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 289. By Product Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 290. By Connectivity Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 291. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 292. By Distribution Channel Map-Market Size (USD Million) & Growth Rate (%), 2023
  • Figure 293. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023
目次
Product Code: MX10948

Global Smart Insulin Pens Market size was valued at USD 51.4 million in 2023, expected to reach USD 129.09 million in 2031 with a CAGR of 12.2% for the forecast period between 2024 and 2031F. Numerous factors are propelling the global smart insulin pens market forward, including the increasing prevalence of diabetes, better management of glycaemic levels, increased patient convenience, ongoing technological progress, a heightened emphasis on telehealth, growing awareness, minimized medication error risk, and potential healthcare cost reductions.

The global smart insulin pens market signifies a significant leap forward in diabetes management. These groundbreaking devices have revolutionized the insulin administration process for people with diabetes, providing them with improved accuracy, convenience, and data-driven insights to improve their overall well-being and quality of life. The escalating global diabetes prevalence and the growing need for efficient and user-friendly diabetes management tools have fuelled the expansion of the global smart insulin pens market. Both healthcare providers and patients are increasingly acknowledging the potential of these devices to improve insulin therapy, leading to more effective glycaemic control and a reduction in the long-term complications associated with diabetes.

With the evolution of technology and the introduction of increasingly sophisticated features and connectivity choices by manufacturers, the global smart insulin pens market is positioned for ongoing growth. Smart insulin pens are furnished with technology that facilitates automated and precise dose calculations, diminishing the potential for human errors during insulin administration. These devices frequently establish wireless connections with smartphone applications, enabling users to track their insulin dosing history, blood glucose levels, and other vital data. This presents a promising outlook for improved diabetes management and increased independence for individuals with this chronic condition.

Growing Awareness

The increased awareness of using smart methods to monitor and control diabetes has led to significant growth in the global smart insulin pens market. Diabetes care is transitioning from traditional in-person office visits to synchronous telehealth methods, such as video consultations, and increasingly, asynchronous digital healthcare services, primarily provided by emerging players in the market. In the United States, the utilization of insulin pens has witnessed a consistent rise over the past few decades, becoming the preferred mode of insulin delivery for both type 1 diabetes (T1D) and type 2 diabetes (T2D) patients. Insulin pens now dominate the market among commercially insured individuals. Patients opt for insulin pens due to their high satisfaction levels and user-friendliness compared to insulin vial and syringe methods. These pens offer superior dose accuracy, leading to improved insulin adherence. Moreover, insulin pen usage has demonstrated better glycaemic controls, reducing HbA1c levels and minimizing hyperglycemia. Despite initial higher costs, insulin pens translate into lower total healthcare expenses, resulting in fewer hospitalizations, diabetes-related admissions, and instances of hyperglycemia-associated healthcare utilization for users.

Advancements in Technology are Propelling the Market Forward

Innovations in technology have transformed the realm of the global smart insulin pens market. These developments include precise dose computations, immediate smartphone data integration, and user-friendly interfaces. The evolution of smart insulin pens provides individuals with efficient means of managing their health, ultimately resulting in enhanced well-being and a better quality of life. For example, in March 2023, Diabeloop, a trailblazer in Automated Insulin Delivery, revealed a partnership with Novo Nordisk, a prominent global healthcare firm. Their joint effort focuses on advancing an interoperability strategy incorporating connected insulin pens. The agreement involves the integration of Diabeloop's self-learning algorithm for Multiple Daily Injections (MDI) therapy, DBL-4pen™, with Novo Nordisk's connected and reusable insulin pens, including NovoPen® 6 and NovoPen Echo® Plus.

Government Initiatives

Government programs focusing on smart insulin pens are pivotal in tackling the worldwide diabetes crisis and improving the well-being of those afflicted with the condition. Governments efforts give a huge boost to global smart insulin pens market. These efforts reflect a forward-looking approach governments took to combat the increasing incidence of diabetes and the escalating need for cutting-edge solutions in diabetes care and management. On January 1, 2023, a notable development occurred as smart insulin pens were incorporated into Medicare Part D by the US government. This means that individuals enrolled in Medicare who rely on smart insulin pens will now have their expenses capped at a maximum of $35 per month for a one-month supply of each approved insulin product. This pivotal inclusion of smart insulin pens in Medicare Part D was mandated under the Affordable Care Act, commonly known as Obamacare. The ACA mandates Medicare to encompass specific categories of diabetes-related supplies, among them being insulin pens. Such initiatives have a large impact on the global smart insulin pens market.

Growing Demand for Bluetooth Devices

The advent of Bluetooth-enabled smart insulin pens marks a substantial advancement in global smart insulin pens market. These cutting-edge tools amalgamate the precision inherent in conventional insulin pens with the capabilities of Bluetooth connectivity, presenting users with a cohesive and data-centric methodology for managing their insulin therapy. By facilitating immediate data transfer to smartphones and other suitable devices, these smart insulin pens empower individuals managing diabetes to meticulously monitor their insulin doses, oversee blood glucose levels, receive dose guidance, and seamlessly communicate vital health data with healthcare professionals. As an example, in December 2022, Biocorp, a French firm specializing in medical devices and drug delivery systems, unveiled its FDA 510(k) clearance to commercialize the Mallya smart medical device, designed to interface with insulin pens. Mallya, functioning as a smart sensor, seamlessly affixes to insulin pen injectors, effectively transforming them into connected devices via bluetooth.

Disposable Smart Insulin Pens are Becoming More Popular

Disposable smart insulin pens are reshaping diabetes management by merging the simplicity of one-time-use pens with state-of-the-art technology, ultimately influencing the global smart insulin pens market. These compact instruments come pre-filled with insulin and boast smart capabilities like dosage monitoring, reminders, and wireless connectivity. This enables users to administer insulin with accuracy while effortlessly overseeing their treatment progress. The disposability factor removes the necessity for cartridge swaps, streamlining insulin administration and boosting patient adherence. As an example, in November 2021, the French multinational pharmaceutical and healthcare company Sanofi and the Swiss multinational healthcare company Roche established a collaborative effort in France. They united their efforts to promote the utilization of a connected accessory designed for disposable insulin pens. Together, they will create an educational program for healthcare professionals, including physicians and retail pharmacists, focusing on the Biocorp product known as Mallya.

Impact of COVID-19

COVID-19 pandemic had a huge impact on the global smart insulin pens market. On one hand, the demand for smart insulin pens surged during the pandemic, primarily driven by the heightened vulnerability of people with diabetes to severe COVID-19 complications, given their increased susceptibility to respiratory infections. This elevated demand was fueled by the urgency for effective diabetes management to reduce hospitalization risks. Conversely, the pandemic disrupted the supply chain for smart insulin pens as production facilities and distribution networks faced closures and shipping challenges, leading to shortages in certain regions. However, despite these short-term setbacks, the long-term outlook for smart insulin pen sales remains positive. COVID-19 underscored the critical importance of effective diabetes management, shedding light on the role smart insulin pens can play in empowering individuals with diabetes to manage their condition proactively and remotely. This heightened awareness is expected to drive sustained growth in the smart insulin pens market.

Key Players Landscape and Outlook

Amidst the rapidly changing healthcare environment, marked by a strong emphasis on precision, connectivity, and patient-centric care, the global market for smart insulin pens is experiencing a multitude of partnerships and cooperative ventures. These endeavors frequently bring together a diverse array of stakeholders, including pharmaceutical firms, technology enterprises, startups, and healthcare providers, who combine their knowledge and resources with the goal of creating advanced smart insulin pens. These next-generation devices aim not only to enhance insulin delivery precision but also to offer users immediate data insights and the ability to remotely monitor their insulin therapy. In May 2021, Eli Lilly & Co., an American pharmaceutical company, took steps to ensure the compatibility of its forthcoming connected insulin pen system with various daily diabetes management platforms by entering into compatibility agreements with four global providers. These agreements encompass a range of offerings, such as glucose monitoring sensors, digital health solutions, and other resources provided by Roche, Dexcom, Glooko, and myDiabby Healthcare.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on Global Smart Insulin Pens Market

4. Executive Summary

5. Global Smart Insulin Pens Market Outlook, 2014-2031F

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
    • 5.1.2. By Volume
  • 5.2. By Type
    • 5.2.1. First Generation Pens
    • 5.2.2. Second Generation Pens
  • 5.3. By Indications
    • 5.3.1. Type 1 Diabetes
    • 5.3.2. Type 2 Diabetes
  • 5.4. By Usability
    • 5.4.1. Disposable
    • 5.4.2. Reusable
  • 5.5. By Product
    • 5.5.1. Smart Insulin Pens
    • 5.5.2. Adaptors for Conventional Pens
  • 5.6. By End-user
    • 5.6.1. Hospital and Clinics
    • 5.6.2. Ambulatory Surgical Centers
    • 5.6.3. Home Care Settings
  • 5.7. By Distribution Channel
    • 5.7.1. Clinics and Ambulatory Surgical Centers
    • 5.7.2. E-commerce
    • 5.7.3. Retail Pharmacies
  • 5.8. By Region
    • 5.8.1. North America
    • 5.8.2. South America
    • 5.8.3. Europe
    • 5.8.4. Asia-Pacific
    • 5.8.5. Middle East and Africa
  • 5.9. By Company Market Share (%), 2023

6. Global Malaria Vaccine Market Outlook, By Region, 2014-2031F

  • 6.1. North America*
    • 6.1.1. Market Size & Forecast
      • 6.1.1.1. Value
      • 6.1.1.2. Volume
    • 6.1.2. By Type
      • 6.1.2.1. First Generation Pens
      • 6.1.2.2. Second Generation Pens
    • 6.1.3. By Indication
      • 6.1.3.1. Type 1 Diabetes
      • 6.1.3.2. Type 2 Diabetes
    • 6.1.4. By Usability
      • 6.1.4.1. Disposable
      • 6.1.4.2. Reusable
    • 6.1.5. By Product
      • 6.1.5.1. Smart Insulin Pens
      • 6.1.5.2. Adaptors for Conventional Pens
    • 6.1.6. By End-user
      • 6.1.6.1. Hospital and Clinics
      • 6.1.6.2. Ambulatory Surgical Centers
      • 6.1.6.3. Home Care Settings
    • 6.1.7. By Distribution Channel
      • 6.1.7.1. Clinics and Ambulatory Surgical Centers
      • 6.1.7.2. E-commerce
      • 6.1.7.3. Retail Pharmacies
    • 6.1.8. United States*
      • 6.1.8.1. Market Size & Forecast
      • 6.1.8.1.1. Value
      • 6.1.8.1.2. Volume
      • 6.1.8.2. By Type
      • 6.1.8.2.1. First Generation Pens
      • 6.1.8.2.2. Second Generation Pens
      • 6.1.8.3. By Indication
      • 6.1.8.3.1. Type 1 Diabetes
      • 6.1.8.3.2. Type 2 Diabetes
      • 6.1.8.4. By Usability
      • 6.1.8.4.1. Disposable
      • 6.1.8.4.2. Reusable
      • 6.1.8.5. By Product
      • 6.1.8.5.1. Smart Insulin Pens
      • 6.1.8.5.2. Adaptors for Conventional Pens
      • 6.1.8.6. By End-user
      • 6.1.8.6.1. Hospital and Clinics
      • 6.1.8.6.2. Ambulatory Surgical Centers
      • 6.1.8.6.3. Home Care Settings
      • 6.1.8.7. By Distribution Channel
      • 6.1.8.7.1. Clinics and Ambulatory Surgical Centers
      • 6.1.8.7.2. E-commerce
      • 6.1.8.7.3. Retail Pharmacies
      • 6.1.8.8. By Region
      • 6.1.8.8.1. North America
      • 6.1.8.8.2. South America
      • 6.1.8.8.3. Europe
      • 6.1.8.8.4. Asia-Pacific
      • 6.1.8.8.5. Middle East and Africa
    • 6.1.9. Canada
    • 6.1.10. Mexico

All segments will be provided for all regions and countries covered:

  • 6.2. Europe
    • 6.2.1 Germany
    • 6.2.2 France
    • 6.2.3 Italy
    • 6.2.4 United Kingdom
    • 6.2.5 Russia
    • 6.2.6 Netherlands
    • 6.2.7 Spain
    • 6.2.8 Turkey
    • 6.2.9 Poland
  • 6.3. South America
    • 6.3.1. Brazil
    • 6.3.2. Argentina
  • 6.4. Asia Pacific
    • 6.4.1. India
    • 6.4.2. China
    • 6.4.3. Japan
    • 6.4.4. Australia
    • 6.4.5. Vietnam
    • 6.4.6. South Korea
    • 6.4.7. Indonesia
    • 6.4.8. Philippines
  • 6.5. Middle East & Africa
    • 6.5.1. Saudi Arabia
    • 6.5.2. UAE
    • 6.5.3. South Africa

7. Market Mapping, 2023

  • 7.1. By Type
  • 7.2. By Indication
  • 7.3. By Usability
  • 7.4. By Product
  • 7.5. By End-user
  • 7.6. By Distributional Channel
  • 7.7. By Region

8. Macro Environment and Industry Structure

  • 8.1. Supply Demand Analysis
  • 8.2. Import Export Analysis
  • 8.3. Value Chain Analysis
  • 8.4. PESTEL Analysis
    • 8.4.1. Political Factors
    • 8.4.2. Economic System
    • 8.4.3. Social Implications
    • 8.4.4. Technological Advancements
    • 8.4.5. Environmental Impacts
    • 8.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 8.5. Porter's Five Forces Analysis
    • 8.5.1. Supplier Power
    • 8.5.2. Buyer Power
    • 8.5.3. Substitution Threat
    • 8.5.4. Threat from New Entrant
    • 8.5.5. Competitive Rivalry

9. Market Dynamics

  • 9.1. Growth Drivers
  • 9.2. Growth Inhibitors (Challenges and Restraints)

10. Regulatory Framework and Innovation

  • 10.1 Clinical Trials
  • 10.2 Patent Landscape
  • 10.3 Regulatory Approvals
  • 10.4 Innovations/Emerging Technologies

11. Key Players Landscape

  • 11.1. Competition Matrix of Top Five Market Leaders
  • 11.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 11.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 11.4. SWOT Analysis (For Five Market Players)
  • 11.5. Patent Analysis (If Applicable)

12. Pricing Analysis

13. Case Studies

14. Key Players Outlook

  • 14.1. Novo Nordisk A/S
    • 14.1.1. Company Details
    • 14.1.2. Key Management Personnel
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As reported)
    • 14.1.5. Key Market Focus & Geographical Presence
    • 14.1.6. Recent Developments
  • 14.2. Medtronic plc.
  • 14.3. Sanofi S.A.
  • 14.4. Eli Lilly International Corp.
  • 14.5. Dexcom, Inc.
  • 14.6. Emperra GmbH E-Health Technologies
  • 14.7. Bigfoot Biomedical, INC.
  • 14.8. Jiangsu Delfu medical device Co. Ltd.
  • 14.9. Digital Medics Pty Ltd.
  • 14.10. Glooko XT
  • 14.11. Biocorp Production
  • 14.12. Pendiq GmbH

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

15. Strategic Recommendations

16. About Us & Disclaimer